|Generic Drug Strategies
The generic drug segment is a rapidly evolving and highly competitive market that lacks a true data compass to assist decision makers in mapping strategies for success in this segment. Attempting to determine the optimal time to file an ANDA application is a process that can be worth significant profits for first-to-filers. But it is a process that is marked by little in the way of analytical decision support and in which litigation has become a staple defensive mechanism for both the filer and the branded drug owner. As of June 28, 2017 there were 7,582 approved ANDAs for active prescription drugs. These products are currently marketed and supplied by a growing number of companies. Competition among the various drug and therapeutic classes is uneven, with the top ten segments accounting for a disproportionate level of activity and revenue. Understanding the underlying factors affecting business performance is key to attaining financial targets.
Essential Data Driven Market Knowledge
Each day countless management decisions are made based upon a combination of acquired knowledge, experience, intuition and factual information. Because it is constantly changing, it is the information/data element that is the key variable in the quality of business decisions. The value of market research lies in its ability to assemble, collate, analyze and present changing information in a way that is at once relevant, understandable and contextual so that end users can maximize its utility in management decision support. At AMD our mission is to provide a view, or vision, of the evolving complexities of a defined business component, segment, sector, market and/or industry, and a clear and concise analysis of what probably lies ahead in terms of the influence of factors that may not be readily evident in the course of daily management activity.